Real-time enrollment status for this endometrial cancer clinical trial
Current Status
Unknown
Checked: April 18, 2026 at 12:24 AM UTC
| NCT Number | NCT05705505 |
| Recruiting Status | Unknown |
| Condition | Endometrial Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Traws Pharma, Inc. |
| Last Updated on CT.gov | December 12, 2023 (Dec 12, 2023) |
As of April 18, 2026: Clinical trial NCT05705505 is currently unknown participants. This clinical trial study for endometrial cancer is not currently accepting new participants at 8 locations across the United States. The study is sponsored by Traws Pharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05705505 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05705505 was last updated Dec 12, 2023 (December 12, 2023). HelloStudys verifies this status automatically.